The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

amphoramedical.com

Executives

1

Board of Directors

2

Amphora Medical Board of Directors

2 Board of directors

Amphora Medical has 2 board of directors, including Peter Shagory.

Name

Firm

Work History

Other Seats

Peter Shagory

Amphora Medical

Robert Weisskoff

Robert Weisskoff, Partner, joined F-Prime Capital in 2004. Robert has worked extensively in both academia and the bioscience industry for thirty years. Prior to F-Prime, he held various senior roles in R&D and Business Development at both pharmaceutical and medical device companies. In his academic career, Dr. Weisskoff was Associate Professor of Radiology at Harvard Medical School, on the faculty of the Harvard-MIT Health Sciences Technology (HST) Program, and performed research at Massachusetts General Hospital, where he was Associate Director of the MGH-NMR Center. There he worked at the intersection of basic research, medical technology development, and clinical research in a variety of areas. Robert is the author of over 100 peer-reviewed scientific papers, and an inventor on 6 US patents. Robert holds a Ph.D. in Physics from the Massachusetts Institute of Technology and an M.B.A. from Columbia University. He received his A.B. degree in Physics from Harvard University, graduating magna cum laude and Phi Beta Kappa. Robert serves on the Board of Directors of Caribou Biosciences, CORE Diagnostics, Farapulse, Plasmagen Biosciences, Promentis Pharmaceuticals, ShouTi, Tempest Therapeutics, Trivitron Healthcare, Xilio Therapeutics and Zenflow, Inc. He has previously served on the boards of Accuri Cytometers (acquired by Becton Dickinson), Ikano Therapeutics (acquired by UCB), Laurus Labs (NSE:LAURUSLABS), Surface Oncology (NASDAQ:SURF), Tetraphase (NASDAQ:TTPH), Transave (NASDAQ:INSM), Topaz (acquired by Sanofi Pasteur), and ViewRay (NASDAQ:VRAY).

Amphora Medical

Name

Peter Shagory

Robert Weisskoff

Firm

Work History

Robert Weisskoff, Partner, joined F-Prime Capital in 2004. Robert has worked extensively in both academia and the bioscience industry for thirty years. Prior to F-Prime, he held various senior roles in R&D and Business Development at both pharmaceutical and medical device companies. In his academic career, Dr. Weisskoff was Associate Professor of Radiology at Harvard Medical School, on the faculty of the Harvard-MIT Health Sciences Technology (HST) Program, and performed research at Massachusetts General Hospital, where he was Associate Director of the MGH-NMR Center. There he worked at the intersection of basic research, medical technology development, and clinical research in a variety of areas. Robert is the author of over 100 peer-reviewed scientific papers, and an inventor on 6 US patents. Robert holds a Ph.D. in Physics from the Massachusetts Institute of Technology and an M.B.A. from Columbia University. He received his A.B. degree in Physics from Harvard University, graduating magna cum laude and Phi Beta Kappa. Robert serves on the Board of Directors of Caribou Biosciences, CORE Diagnostics, Farapulse, Plasmagen Biosciences, Promentis Pharmaceuticals, ShouTi, Tempest Therapeutics, Trivitron Healthcare, Xilio Therapeutics and Zenflow, Inc. He has previously served on the boards of Accuri Cytometers (acquired by Becton Dickinson), Ikano Therapeutics (acquired by UCB), Laurus Labs (NSE:LAURUSLABS), Surface Oncology (NASDAQ:SURF), Tetraphase (NASDAQ:TTPH), Transave (NASDAQ:INSM), Topaz (acquired by Sanofi Pasteur), and ViewRay (NASDAQ:VRAY).

Other Seats

Amphora Medical

Amphora Medical

Amphora Medical Management Team

1 Team Member

Amphora Medical has 1 executive. Amphora Medical's founder is Danny Sachs.

Name

Work History

Title

Status

Danny Sachs

Kspine, Harvard Medical School, Eli Lilly and Company, Spray Venture Partners, Segulah, and Investor Growth Capital

Founder

Current

Name

Danny Sachs

Work History

Kspine, Harvard Medical School, Eli Lilly and Company, Spray Venture Partners, Segulah, and Investor Growth Capital

Title

Founder

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.